SCHEMBL5651929

SCHEMBL5651929

NC(=O)CC[C@H](NC1Cc2ccccc2C1)C(=O)OC(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 3/20 0.46
KDM4E B2RXH2 1/20 0.45
MMP2 P08253 2/20 0.41
MMP9 P14780 2/20 0.41
SLC1A5 Q15758 1/20 0.40
HDAC1 Q13547 1/20 0.37
SMYD3 Q9H7B4 1/20 0.37
MCHR1 Q99705 1/20 0.36
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
TAOK1 Q7L7X3 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4356541 0.90 KDM4E (0.48) KDM4EMMP2MMP9SLC1A5SMYD3
SCHEMBL4364695 0.87 KDM4E (0.45) KDM4EMMP2MMP9SLC1A5SMYD3
SCHEMBL5652199 0.80 KDM4E (0.45) KDM4EMMP2MMP9SLC1A5PDCD1
SCHEMBL5651555 0.79 KDM4E (0.51) KDM4EMMP2MMP9SLC1A5PDCD1
SCHEMBL4357430 0.77 KDM4E (0.46) KDM4EMMP2MMP9SLC1A5HDAC1
SCHEMBL5651549 0.75 KDM4E (0.44) KDM4EMMP2MMP9SLC1A5HDAC1
SCHEMBL2247315 0.75 KDM4E (0.46) KDM4EMMP2MMP9SLC1A5PDCD1
SCHEMBL4621031 0.75 KDM4E (0.46) KDM4EMMP2MMP9SLC1A5PDCD1
SCHEMBL4365446 0.75 KDM4E (0.46) KDM4EMMP2MMP9SLC1A5PDCD1
SCHEMBL4364953 0.74 CD274 (0.53) CD274NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043066-A1 Glutamate aggrecanase inhibitors WYETH (US) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043066-A1 Glutamate aggrecanase inhibitors ADAMTS5, ADAMTS1, ADAMTS7 PRMT5 1004/4885KDM4E 1232/4885MMP2 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.